Comparative effectiveness and toxicity of CAR-T therapy versus blinatumomab in adult B-cell acute lymphoblastic leukemia: A real-world propensity-matched analysis

Authors

• Colton Davis, Rochester Regional HealthFollow
• Adithya Nagendran, Rochester Regional HealthFollow
• Anushree Venkatesh Murthy, Rochester Regional HealthFollow
• Logesh Durairaj, Rochester Regional HealthFollow
• Madho Mal
• Nayanika Chowdary Tummala
• Love Kumar
• Julia Grandinetti

Department

Internal Medicine

Document Type

Conference Proceeding

Publication Title

Journal of Clinical Oncology

Conference Name

American Society of Clinical Oncology (ASCO) Annual Meeting

Conference Date

2026-05-29 - 2026-06-02

First Page

6551

DOI

10.1200/JCO.2026.44.16_suppl.6551

Volume

44

Issue

16_suppl

Publication Date

6-1-2026

Recommended Citation

Davis, C., Nagendran, A., Venkatesh Murthy, A., Durairaj, L., Mal, M., Tummala, N. C., Kumar, L., & Grandinetti, J. (2026). Comparative effectiveness and toxicity of CAR-T therapy versus blinatumomab in adult B-cell acute lymphoblastic leukemia: A real-world propensity-matched analysis. Journal of Clinical Oncology, 44 (16_suppl), 6551. https://doi.org/10.1200/JCO.2026.44.16_suppl.6551